novo nordisk ozempic - Search News

Novo Nordisk’s stock is rallying

MarketWatch on MSN · 9h

Novo Nordisk’s stock is rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer.

Wall Street Journal · 8h

Novo Nordisk Stock Rallies on Weight-Loss Retreat by Hims & Hers

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to Novo Nordisk's Wegovy and Ozempic weight-loss drugs. Hims stock stood about 17% lower at under $42.

The Motley Fool on MSN · 12d

Why Novo Nordisk Stock Keeps Going Down

Novo Nordisk ( NVO -1.22%) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, beginning with a 3% decline on Monday from last Friday's close, and falling another 2.6% through 10:10 a.m. ET on Thursday.

FDA, Ozempic

NBC Washington · 48m

Costs could rise for people using copycats of Ozempic, Wegovy

People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide shortage of the weight-loss and diabetes drugs has ended. Drugmaker Novo Nordisk’s supply of the popular GLP-1 prescriptions now meets or exceeds demand,

CNN on MSN · 4d

Ozempic and Wegovy are no longer in shortage, FDA says

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

Becker's Hospital Review · 1d

FDA sets deadline to end sales of Ozempic, Wegovy copycats

Semaglutide — the key ingredient in Ozempic and Wegovy — had been in shortage since 2022. Now that supply has stabilized, state-licensed compounding pharmacies and physicians must stop selling compounded semaglutide by April 22, while outsourcing facilities have until May 22 to cease production and distribution.

1hon MSN

Hims & Hers can't sell off-brand Ozempic forever. But it can still sell these weight loss drugs

Hims & Hers (HIMS) made a killing last year selling an off-brand version of Ozempic, but with the drug’s shortage now over, ...

4don MSN

Novo’s Ozempic Shortage Is Declared Over, Hitting Copycats

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...

4d

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

4don MSN

FDA says Ozempic shortage is over, chilling boom in off-brand versions

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

ConsumerAffairs1h

Hims & Hers withdraws from Wegovy, Ozempic market

Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S ...

6hon MSN

In China you can get Ozempic and Wegovy within the hour for just $100 a month

Delivery apps are allowing Chinese citizens to get their hands on the popular weight-loss and diabetes drugs at the touch of ...

Channel 4 News3h

Should we be worried about deaths linked to weight loss jabs including Ozempic?

Medical treatments, including jabs used for weight loss, are monitored in part using the Medicines and Healthcare products ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results